Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04865432 · ClinicalTrials.gov registry record · NA
Solius UV Light Source in Improving Serum Levels of 25-hydroxyvitamin D
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04865432: Completed NA study, sponsored by Boston University.
NCT04865432 is a NA study that has completed, run by Boston University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04865432, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a feasibility interventional study seeking to determine the safety and efficacy of the Solius Photobiologic System in increasing the serum levels of 25(OH)D in a vitamin D deficient/insufficient adult population.
Primary Outcome
Serum 25-hydroxyvitamin D level at 4 weeks of intervention (the end of study)
Interventions
- DEVICE UVB treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-08-24 |
| Est. Completion | 2021-12-12 |
| Phase | NA |
What the finished NCT04865432 record still lists
NCT04865432 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which UVB treatment is the first listed.
NCT04865432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04865432 about?
NCT04865432 is a clinical study titled "Solius UV Light Source in Improving Serum Levels of 25-hydroxyvitamin D". This is a feasibility interventional study seeking to determine the safety and efficacy of the Solius Photobiologic System in increasing the serum levels of 25(OH)D in a vitamin D deficient/insufficient adult population.
What is the current status of trial NCT04865432?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-08-24. Estimated completion is 2021-12-12.
What interventions are being tested in trial NCT04865432?
The interventions under investigation include: UVB treatment (DEVICE).
Who is sponsoring clinical trial NCT04865432?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04865432's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI